1. Home
  2. PAYS vs NBY Comparison

PAYS vs NBY Comparison

Compare PAYS & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Paysign Inc.

PAYS

Paysign Inc.

N/A

Current Price

$5.41

Market Cap

293.4M

ML Signal

N/A

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

N/A

Current Price

$3.65

Market Cap

398.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
PAYS
NBY
Founded
2001
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
293.4M
398.2M
IPO Year
1998
2007

Fundamental Metrics

Financial Performance
Metric
PAYS
NBY
Price
$5.41
$3.65
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$8.06
N/A
AVG Volume (30 Days)
329.3K
544.0K
Earning Date
11-12-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.13
0.47
Revenue
$74,879,428.00
$10,302,000.00
Revenue This Year
$41.20
$23.91
Revenue Next Year
$20.62
$32.05
P/E Ratio
$41.87
$122.79
Revenue Growth
32.61
390.34
52 Week Low
$1.80
$0.46
52 Week High
$8.88
$4.44

Technical Indicators

Market Signals
Indicator
PAYS
NBY
Relative Strength Index (RSI) 53.08 87.96
Support Level $5.21 $2.66
Resistance Level $5.60 $1.11
Average True Range (ATR) 0.20 0.39
MACD 0.04 0.24
Stochastic Oscillator 65.83 94.36

Price Performance

Historical Comparison
PAYS
NBY

About PAYS Paysign Inc.

PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The Company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The company's revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: